FOXD2 and esophageal squamous cell carcinoma: For example, overexpression of FOXD2-AS1 enhanced DDP-resistance in ESCC tissues and cells, and silencing FOXD2-AS1 improved DDP-resistance in ESCC (Liu H. et al., 2020).